Comprehensive transcriptome and epigenome sequencing of hypoxic breast cancer reveals non-coding RNAs associated with clinicopathological features

Add to your list(s) Download to your calendar using vCal

• Ioannis (Jiannis) Ragoussis, McGill University, Canada and Genome Quebec Innovation Centre
• Monday 09 December 2013, 13:00-14:00
• Cancer Research UK Cambridge Institute, Lecture Theatre.

If you have a question about this talk, please contact Laura Blackburn.

Hypoxia is an important physiological stress with a central role in many responses including adaptation to altitude, growth and development, as well as major pathophysiological processes such as ischaemia and cancer. Pan-genomic analyses of these responses have focused on protein-coding genes. However, it is now recognised that many transcripts have functions that do not include coding for proteins (noncoding RNA ). Here, we comprehensively profile this non-coding transcriptional output in hypoxia. We undertook an integrated pan-genomic analysis of normoxic and hypoxic MCF7 breast cancer cells, employing RNA -seq together with ChIP-seq for the major hypoxia-inducible transcription factor HIF and for chromosomal markers of active transcription (RNApol2 and histone H3K4 methylation). We further assessed these responses following knockdown of HIF transcription factors using RNAi. We establish a computational pipeline of strand specific ribodepleted RNA -seq data to detect regulated non-coding transcripts including piwiRNA, miRNA, tRNA, sn/snoRNA, and lncRNA. We describe 105 previously annotated transcripts bearing chromosomal marks of bona-fide genes. Four hypoxically induced lncRNAs were then analysed in 148 breast tumours and associated with clinicopathological features. Our findings extend knowledge of the hypoxic transcriptional response into the spectrum of noncoding transcripts. We demonstrate that HIF can transcriptionally activate lncRNAs in addition to coding transcripts and link these to clinicopathological features. These HIF -regulated non-coding transcripts have the potential to act as new biomarkers for breast cancer as well as potentially novel therapeutic targets.

This talk is part of the CRUK CI website talks listing series.

This talk is included in these lists:

• Biology
• CRUK CI Seminars
• Cancer Research UK Cambridge Institute, Lecture Theatre
• Life Sciences
• Life Sciences
• ME Seminar
• cri
• my_list
• other talks
• se393's list
• sfm36

Note that ex-directory lists are not shown.